Project Details
Description
Intermediate-Size Patient Population Expanded Access to Bezuclastinib for Patients with NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
| Status | Active |
|---|---|
| Effective start/end date | 12/17/25 → 12/16/36 |
Funding
- COGENT BIOSCIENCES, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.